| Document Date: 2012-11-30 20:13:43
Open Document File Size: 291,02 KBShare Result on Facebook
City London / / Company Policy Cures / Product Development Partnerships / / Currency USD / cent / / / IndustryTerm not-for-profit / pharmaceuticals / neglected disease products / research / health products / decision-making tools / pharmaceutical / vector control products / / MedicalCondition pneumonia / TB / HIV / bacterial pneumonia / neglected disease / malaria / neglected diseases / INVESTING IN R&D FOR NEGLECTED DISEASES / every disease / sickness / diseases / few diseases / infections / meningitis / tuberculosis / non-commercial diseases / / Organization Melinda Gates Foundation / civil society / World Health Organization / Academy of Medical Sciences / / Person Mary Moran / / / Position Executive Director / report author / / URL www.policycures.org/g-finder2012.html / /
SocialTag |
PRESS RELEASE EMBARGO: 00.05 Monday 3rd December (Midnight, Sunday 2nd December), London time INVESTING IN R&D FOR NEGLECTED DISEASES – TIME FOR GOVERNMENTS TO BITE THE BULLET London, 3rd December 2012 – A 5-year re